Key result
Transcatheter tricuspid valve replacement significantly reduced RV mid diameter (p=0.002) and PASP (p=0.05) while increasing forward cardiac output (p=0.023) at 5-9 months.
Why the study?
While transcatheter tricuspid valve replacement (TTVR) improves quality of life in severe tricuspid regurgitation, post-procedural changes in right ventricular morphology and physiology and their association with cardiac function and pulmonary pressures are poorly understood.
Does Transcatheter Tricuspid Valve Replacement (TTVR) induce right ventricular reverse remodelling and changes in cardiac function and pulmonary pressures in patients with symptomatic severe or greater tricuspid regurgitation?
Observational (n=19)
No
Does Transcatheter Tricuspid Valve Replacement (TTVR) induce right ventricular reverse remodelling and changes in cardiac function and pulmonary pressures in patients with symptomatic severe or greater tricuspid regurgitation?
Following transcatheter tricuspid valve replacement, patients experience biphasic right ventricular reverse remodelling with increased forward cardiac output and reduced pulmonary pressures by 5-9 months, despite a decline in conventional longitudinal and area-based RV functional indices.
Supports RV reverse remodelling post-TTVR; hypothesis-generating and requires randomized trials before clinical adoption.
Introduction Transcatheter Tricuspid Valve Replacement (TTVR) is a minimally invasive treatment for severe tricuspid regurgitation (TR). While significant improvement in quality-of-life post-intervention has been demonstrated, the post-procedural changes in right ventricular (RV) morphology and physiology are poorly understood. Purpose To determine RV morphological changes post-intervention and their association with changes in cardiac function and pulmonary pressures. Secondary aim was to explore associations between changes in the latter 2. Methods This is a single-centre observational analysis of patients who underwent TTVR for symptomatic ≥ severe TR at a specialist referral centre from June 2024 to September 2025. Routine 2-dimensional transthoracic echocardiography (TTE) at timepoints: pre-procedure, <48hrs, 1-3 and 5-9 months was used. Associations in TTE-measured RV size, function, PASP and cardiac output (CO) were analysed using univariate Pearson’s or Kendall’s Tau correlation coefficient as appropriate, and temporal changes in parameters with paired t-tests. Results 19 patients underwent TTVR: 12 (63%) female, mean age 82 years (IQR 79-84). Pre-intervention, 26% had severe, 26% massive and 47% torrential TR. Post-intervention all patients had ≤mild-moderate TR, with 100% procedural success and no conversion to surgery. Significant RV reverse remodelling was seen by 5-9 months (Fig. 1). Decrease in RV base diameter trended towards significance at 1-3 months (p=0.114). RV mid diameter significantly declined from baseline by 5-9 months (p=0.002). Similarly, a significant decline in RV end diastolic area (EDA) at 1–3 months was seen (p=0.036). RV end systolic area (ESA) increased significantly at 1-3 months (p=0.034), later decreasing; however, baseline to 5-9 months slightly increased without significance (p=0.143). RV length shows similar trends. A significant decline in RV function was seen by 5-9 months: TAPSE (p<0.001), RV S’ (p=0.005), FAC (p<0.001) and global RV function (p=0.005). Forward CO significantly increased from baseline (p=0.023). PASP saw a significant decline (p=0.05). Baseline PASP and RV-PA coupling (TAPSE/PASP) correlated with early RV reverse remodelling at 1-3 months (Tables 1 and 2), but not at 5-9 months. Curiously, there was no clear relationship between measures of RV function and output, and between RV output and RV-PA coupling. Conclusion This study shows significant changes in RV structure and function, forward CO and PASP post-TTVR. The changes in RV morphology, especially RV ESA and length, along with the corresponding changes in RV function, forward output and PASP, suggest two phases of reverse remodelling: initial unloading of the RV overload, followed by a later phase – perhaps myocardial muscle fibre shortening. A continuous decline in metrics of RV function was observed, while forward CO increased. Baseline PASP correlated with the extent of early reverse remodelling.
No takes yet. Share an insight, caveat, or question.
Gopal et al. (2026) conducted an observational in Symptomatic severe or greater tricuspid regurgitation (n=19). Transcatheter Tricuspid Valve Replacement (TTVR) vs. Pre-procedure baseline was evaluated on Right ventricular (RV) morphological changes, cardiac function, and pulmonary pressures (p=0.002). Transcatheter tricuspid valve replacement significantly reduced RV mid diameter (p=0.002) and PASP (p=0.05) while increasing forward cardiac output (p=0.023) at 5-9 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: